financetom
Business
financetom
/
Business
/
Fed Likely to Stay Put Until March 2026 Amid Tariffs-Related Uncertainty, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fed Likely to Stay Put Until March 2026 Amid Tariffs-Related Uncertainty, Morgan Stanley Says
Apr 8, 2025 1:35 PM

04:16 PM EDT, 04/08/2025 (MT Newswires) -- The Federal Reserve is expected to keep its monetary policy on hold throughout this year and resume cutting interest rates in March 2026 as the US central bank monitors the impact of tariffs on inflation and economic activity, Morgan Stanley said.

On Friday, Fed Chair Jerome Powell said the Trump administration's tariffs will likely drive inflation higher and slow down US economic growth.

"We are well positioned to wait for greater clarity before considering any adjustments to our policy stance," Powell said at the time. "It is too soon to say what will be the appropriate path for monetary policy."

Powell's remarks suggest that tariffs "caused a shift in the Fed's thinking," Morgan Stanley Chief US Economist Michael Gapen said in a note emailed on Tuesday. "While the Fed will be inclined to look through inflation and reduce the degree of policy restriction to support growth in economic activity, we think it will take time for the Fed to conclude tariff-induced inflation is transitory."

The Fed is not expected to deliver any rate cuts in 2025, with an easing cycle likely to begin in March 2026, Gapen said. However, if the economy enters a recession, it could mean "earlier and larger up-front cuts," he said.

Last week, the Trump administration announced broad-scale tariffs on US imports, including from China, which responded with its own retaliatory duties. China's commerce ministry reportedly said Tuesday that Beijing will "fight to the end" if the US imposes the additional 50% tariffs threatened by US President Donald Trump on Monday.

The Trump administration is moving forward with the additional tariffs on China that will bring the total rate of levies on the Asian country to 104%, a White House official told CNBC. The new rate goes into effect at 12:01 am ET Wednesday.

Morgan Stanley lowered its US economic growth forecasts to 0.8% and 0.7% for 2025 and 2026, respectively, from 1.5% and 1.2%. The investment bank lifted its 2025 estimates for headline and core personal consumption expenditures inflation by about one percentage point each to 3.4% and 3.9%, respectively.

The investment bank forecasts the terminal rate to reach 2.50% to 2.75% by late 2026. Last month, the Federal Open Market Committee left its policy rate steady in the 4.25% to 4.50% range for a second straight meeting.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Sanctions delay to Russian zinc mine causes supply miscalculation, sources say
Exclusive-Sanctions delay to Russian zinc mine causes supply miscalculation, sources say
Nov 3, 2024
LONDON (Reuters) - Western sanctions on Russia's zinc miner Ozernoye have left it struggling to replace equipment needed to ramp up output, three sources with knowledge of the matter said, meaning mined zinc supply forecasts for 2025 are likely to be too high. Without Ozernoye's substantial contribution to global mined zinc supply next year, a shortage of zinc concentrate -...
Goldman-backed drug developer Septerna raises $288 mln in US IPO
Goldman-backed drug developer Septerna raises $288 mln in US IPO
Nov 3, 2024
* Septerna now offering 16 mln shares vs 15.3 mln shares earlier * Sets IPO price at $18 a share * Drug developer backed by Goldman, Third Rock Ventures * Listing follows a spate of biotech IPOs since September (Adds pricing of IPO in paragraphs 1-2, background in paragraph 3) By Arasu Kannagi Basil Oct 24 (Reuters) - Biotech firm...
Swiss chemical maker Sika's nine-month sales rise 5.5%
Swiss chemical maker Sika's nine-month sales rise 5.5%
Nov 3, 2024
Oct 25 (Reuters) - Swiss industrial and construction chemicals company Sika reported a 5.5% increase in sales for the first nine months of 2024 on Friday, and confirmed its outlook for the year. The company, whose chemical additives are used to strengthen and waterproof building materials in walls, floors and roofs, said sales rose to 8.91 billion Swiss francs ($10.29...
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Nov 3, 2024
The U.S. stock market exhibited a mixed performance on Thursday. The Nasdaq Composite gained over 130 points, while the Dow traded down 0.3% to 42,374.36. The S&P 500 also rose, gaining 0.2% to 5,809.86. These are the top stocks that gained the attention of retail traders and investors throughout the day: Monopar Therapeutics Inc. ( MNPR ) skyrocketed by 605.40%...
Copyright 2023-2025 - www.financetom.com All Rights Reserved